Royal Bank of Canada’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,221
Closed -$7K 8162
2022
Q1
$7K Sell
6,221
-19,126
-75% -$14.4K ﹤0.01% 7163
2021
Q4
$19K Buy
25,347
+12,785
+102% +$10.3K ﹤0.01% 6837
2021
Q3
$12K Buy
12,562
+5,701
+83% +$6.86K ﹤0.01% 6921
2021
Q2
$11K Buy
6,861
+913
+15% +$1.53K ﹤0.01% 6857
2021
Q1
$12K Buy
5,948
+1,300
+28% +$2.7K ﹤0.01% 6741
2020
Q4
$6K Buy
4,648
+4,571
+5,936% +$5.45K ﹤0.01% 6611
2020
Q3
$0 Sell
77
-364
-83% -$443 ﹤0.01% 7119
2020
Q2
$0 Sell
441
-3,065
-87% -$2.83K ﹤0.01% 7059
2020
Q1
$3K Buy
+3,506
New +$3.72K ﹤0.01% 6240
2018
Q4
Sell
-1,735
Closed -$3K 7314
2018
Q3
$3K Buy
1,735
+1,673
+2,698% +$3.25K ﹤0.01% 6461
2018
Q2
$0 Buy
+62
New +$115 ﹤0.01% 6888
2018
Q1
Sell
-14
Closed 6975
2017
Q4
$0 Hold
14
﹤0.01% 7050
2017
Q3
$0 Buy
+14
New +$16 ﹤0.01% 7104
2015
Q4
Sell
-287
Closed -$1K 6906
2015
Q3
$1K Hold
287
﹤0.01% 6539
2015
Q2
$1K Buy
287
+222
+342% +$629 ﹤0.01% 6494
2015
Q1
$0 Buy
+65
New +$241 ﹤0.01% 6492
2013
Q4
Sell
-200
Closed -$3K 6227
2013
Q3
$3K Buy
+200
New +$2.81K ﹤0.01% 5780

Other funds holding MBII

Royal Bank of Canada's MBII Position: Q2 2022 in Review

Royal Bank of Canada sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 6,221 shares — an estimated $7K sold.

Royal Bank of Canada first reported a position in MBII in Q3 2013 and held it in 17 quarters. The position peaked at $19K in Q4 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Royal Bank of Canada reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 6,221 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $7K.
  • Royal Bank of Canada first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 17 quarters.
  • Royal Bank of Canada's Marrone Bio Innovations, Inc. position peaked at $19K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.